Co-delivery of chemotherapeutics and proteins for synergistic therapy.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Advanced Drug Delivery Reviews

• Publication date

  2016-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.addr.2015.10.021PMID 26546464
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nanogel‐Incorporated Physical and Chemical Hybrid Gels for Highly Effective Chemo–Protein Combination Therapy

  2015cited by this paper
• Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer.

  2015cited by this paper
• Tumors: Wounds That Do Not Heal—Redux

  2015cited by this paper
• Core-Cone Structured Monodispersed Mesoporous Silica Nanoparticles with Ultra-large Cavity for Protein Delivery.

  2015cited by this paper
• Immune Checkpoint Blockade in Cancer Therapy.

  2015cited by this paper
• Co-delivery of protein and small molecule therapeutics using nanoparticle-stabilized nanocapsules.

  2015cited by this paper
• Synthetic Nanoparticles for Vaccines and Immunotherapy.

  2015cited by this paper
• Cancer Immunology at the Crossroads : Engineering Engineering New Approaches to Cancer Vaccines

  2015cited by this paper
• The future of immune checkpoint therapy

  2015cited by this paper
• Toroidal-Spiral Particles for Codelivery of Anti-VEGFR-2 Antibody and Irinotecan: A Potential Implant to Hinder Recurrence of Glioblastoma Multiforme

  2014cited by this paper
• Low-dose inhalation of interleukin-2 bio-chemotherapy for the treatment of pulmonary metastases in melanoma patients

  2014cited by this paper
• Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial.

  2014cited by this paper
• CD44-tropic polymeric nanocarrier for breast cancer targeted rapamycin chemotherapy.

  2014cited by this paper
• PLK1shRNA and doxorubicin co-loaded thermosensitive PLGA-PEG-PLGA hydrogels for osteosarcoma treatment.

  2014cited by this paper
• Photoresponsive Protein–Graphene–Protein Hybrid Capsules with Dual Targeted Heat‐Triggered Drug Delivery Approach for Enhanced Tumor Therapy

  2014cited by this paper
• Immunoliposome co-delivery of bufalin and anti-CD40 antibody adjuvant induces synergetic therapeutic efficacy against melanoma

  2014cited by this paper
• Stimuli-sensitive nanopreparations for combination cancer therapy.

  2014cited by this paper
• TRAIL combinations: The new ‘trail’ for cancer therapy (Review)

  2014cited by this paper
• Multifunctional interpenetrating polymer network hydrogels based on methacrylated alginate for the delivery of small molecule drugs and sustained release of protein.

  2014cited by this paper
• Enhancement of cancer therapy efficacy by trastuzumab-conjugated and pH-sensitive nanocapsules with the simultaneous encapsulation of hydrophilic and hydrophobic compounds.

  2014cited by this paper
• Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.

  2014cited by this paper
• Recent progress in multidrug delivery to cancer cells by liposomes.

  2014cited by this paper
• Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer.

  2014cited by this paper
• Gel–Liposome‐Mediated Co‐Delivery of Anticancer Membrane‐Associated Proteins and Small‐Molecule Drugs for Enhanced Therapeutic Efficacy

  2014cited by this paper
• Recent developments in the co-delivery of siRNA and small molecule anticancer drugs for cancer treatment

  2014cited by this paper
• Loco-regional cancer drug therapy: present approaches and rapidly reversible hydrophobization (RRH) of therapeutic agents as the future direction.

  2014cited by this paper
• Checkpoint blocking antibodies in cancer immunotherapy

  2014cited by this paper
• Nanopreparations to overcome multidrug resistance in cancer.

  2013cited by this paper
• At the Bedside: CTLA‐4‐ and PD‐1‐blocking antibodies in cancer immunotherapy

  2013cited by this paper
• Recent progress of in situ formed gels for biomedical applications

  2013cited by this paper
• TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer.

  2013cited by this paper
• Engineering synthetic vaccines using cues from natural immunity.

  2013cited by this paper
• Nano-sized polymers and liposomes designed to deliver combination therapy for cancer.

  2013cited by this paper
• Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents.

  2013cited by this paper
• Direct delivery of functional proteins and enzymes to the cytosol using nanoparticle-stabilized nanocapsules.

  2013cited by this paper
• Clinical comparison between paclitaxel liposome (Lipusu®) and paclitaxel for treatment of patients with metastatic gastric cancer.

  2013cited by this paper
• Antibody-drug conjugates: targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin.

  2013cited by this paper
• Polymeric micelles for multidrug delivery and combination therapy.

  2013cited by this paper
• Materials innovation for co-delivery of diverse therapeutic cargos.

  2013cited by this paper
• Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer.

  2013cited by this paper
• Toward the next-generation nanomedicines: design of multifunctional multiblock polyurethanes for effective cancer treatment.

  2013cited by this paper
• Enzyme-responsive nanoparticles for drug release and diagnostics.

  2012cited by this paper
• Hydrogels for protein delivery.

  2012cited by this paper
• Design of polymeric nanoparticles for biomedical delivery applications.

  2012cited by this paper
• Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

  2012cited by this paper
• Doxil®--the first FDA-approved nano-drug: lessons learned.

  2012cited by this paper
• Ultrathin, bioresponsive and drug-functionalized protein capsules

  2012cited by this paper
• Trastuzumab emtansine for HER2-positive advanced breast cancer.

  2012cited by this paper
• The synergistic effects of low-dose irinotecan and TRAIL on TRAIL-resistant HT-29 colon carcinoma in vitro and in vivo.

  2012cited by this paper
• Stimuli-responsive polymers and nanomaterials for gene delivery and imaging applications.

  2012cited by this paper
• Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression.

  2012cited by this paper
• Concurrent binding and delivery of proteins and lipophilic small molecules using polymeric nanogels.

  2012cited by this paper
• Antibody therapy of cancer

  2012cited by this paper
• Novel supramolecular hydrogel/micelle composite for co-delivery of anticancer drug and growth factor

  2012cited by this paper
• Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy.

  2012cited by this paper
• Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy.

  2011cited by this paper
• Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.

  2011cited by this paper
• Paclitaxel and TRAIL synergize to kill paclitaxel-resistant small cell lung cancer cells through a caspase-independent mechanism mediated through AIF.

  2011cited by this paper
• Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery.

  2011cited by this paper
• Trastuzumab Emtansine: A Unique Antibody-Drug Conjugate in Development for Human Epidermal Growth Factor Receptor 2–Positive Cancer

  2011cited by this paper
• Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery.

  2011cited by this paper
• Antibody-Drug Conjugates of Calicheamicin Derivative: Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin

  2011cited by this paper
• The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect.

  2011cited by this paper
• Antibody Conjugate Therapeutics: Challenges and Potential

  2011cited by this paper
• Synergistic anticancer effects achieved by co-delivery of TRAIL and paclitaxel using cationic polymeric micelles.

  2011cited by this paper
• Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor‐α in chemotherapy of multidrug‐resistant hepatocellular carcinoma

  2010cited by this paper
• Immunologic messenger molecules: cytokines, interferons, and chemokines.

  2010cited by this paper
• Nanoparticle-assisted combination therapies for effective cancer treatment.

  2010cited by this paper
• Delivery of therapeutic proteins.

  2010cited by this paper
• Doxorubicin‐Conjugated Immuno‐Nanoparticles for Intracellular Anticancer Drug Delivery

  2009cited by this paper
• The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles.

  2009cited by this paper
• Engulfing tumors with synthetic extracellular matrices for cancer immunotherapy.

  2009cited by this paper
• Trastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of docetaxel.

  2009cited by this paper
• Chitosan hydrogel containing GMCSF and a cancer drug exerts synergistic anti-tumor effects via the induction of CD8+ T cell-mediated anti-tumor immunity

  2009cited by this paper
• Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines.

  2009cited by this paper
• Modular injectable matrices based on alginate solution/microsphere mixtures that gel in situ and co-deliver immunomodulatory factors.

  2008cited by this paper
• Injectable hydrogels as unique biomedical materials.

  2008cited by this paper
• Protein therapeutics: a summary and pharmacological classification

  2008cited by this paper
• In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery.

  2008cited by this paper
• Synergism of CPT-11 and Apo2L/TRAIL against Two Differentially Sensitive Human Colon Tumor Xenografts

  2008cited by this paper
• Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.

  2008cited by this paper
• Synergy between cetuximab and chemotherapy in tumors of the gastrointestinal tract.

  2008cited by this paper
• Infection-Mimicking Materials to Program Dendritic Cells In Situ

  2008cited by this paper
• Regulation of DR-5 protein and mitochondrial transmembrane potential by gemcitabine, a possible mechanism of gemcitabine-enhanced TRAIL-induced apoptosis.

  2007cited by this paper
• Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200.

  2007cited by this paper
• Bevacizumab plus irinotecan in recurrent glioblastoma multiforme.

  2007cited by this paper
• Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1

  2007cited by this paper
• TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility.

  2006cited by this paper
• Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility.

  2006cited by this paper
• Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer.

  2006cited by this paper
• Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.

  2006cited by this paper
• Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies

  2006cited by this paper
• Polymeric micelles for drug delivery.

  2006cited by this paper
• Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential

  2006cited by this paper
• Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential.

  2006cited by this paper
• Co-delivery of drugs and DNA from cationic core–shell nanoparticles self-assembled from a biodegradable copolymer

  2006cited by this paper
• Combined chemoimmunotherapy of solid tumours: improving vaccines?

  2006cited by this paper
• Recent advances with liposomes as pharmaceutical carriers

  2005cited by this paper
• Inhibition of TGF-β modulates macrophages and vessel maturation in parallel to a lowering of interstitial fluid pressure in experimental carcinoma

  2005cited by this paper
• Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: Pivotal role of p38 MAPK in drug resistance

  2004cited by this paper

• Oleanolic acid and its derivatives in breast cancer therapy: mechanistic insights, structural modifications, and novel delivery strategies

  2026cites this paper
• Bridging the Bioavailability Barriers of Apigenin via Modern Engineering Strategies: A Comprehensive and Critical Review

  2026cites this paper
• Promising Nanotechnology-Based Strategies for Melanoma Treatment

  2025cites this paper
• Graphene Oxide‐Based Gene Modulation in Preferential Elimination of Lung Cancer Cells in a 3D Tumor Microenvironment Model

  2025cites this paper
• Lonidamine dimer-based nanomedicine for overcoming multidrug resistance by manipulating energy metabolism and disrupting redox homeostasis

  2025cites this paper
• Codelivery of Bortezomib and Modified DR5-Selective TRAIL via Amphiphilic Poly(N-vinylpyrrolidone) Bionanocomposites to Overcome Glioblastoma Resistance.

  2025cites this paper
• DFT and MD Investigations of Doxorubicin-Pertuzumab Delivery via PLGA Nanocarriers: Thermodynamic Stability and Optical Properties

  2025cites this paper
• Genetically engineered chondrocyte-mimetic nanoplatform attenuates osteoarthritis by blocking IL-1β and restoring sirtuin-3

  2025cites this paper
• 20 years of flash nanoprecipitation - from controlled precipitation to global medicine.

  2025cites this paper
• Carrier-Free Cisplatin–Dactolisib Nanoparticles for Enhanced Synergistic Antitumor Efficacy

  2025cites this paper
• Mechanistic insights from simulations of drug–drug conjugate nanoclusters for co-delivery across cancer cell membranes

  2025cites this paper
• Synergistic Anticancer Enhancement: Sericin Nanogels Co-Delivery of C3G and Cancer Drugs Irinotecan, Paclitaxel, and Oxaliplatin

  2025cites this paper
• Antioxidant Natural Compounds Integrated with Targeted Protein Degradation: A Multi-Modal Strategy for Alzheimer’s Disease Therapy

  2025cites this paper
• A Self-Amplifying Photodynamic Biomedicine for Cascade Immune Activation Against Triple-Negative Breast Cancer.

  2025cites this paper
• Anti-CD33 antibody enhances liposomal co-delivery of cytarabine and daunorubicin for targeted combination chemotherapy.

  2025cites this paper
• Advancements of nanoscale drug formulations for combination treatment of colorectal cancer.

  2025cites this paper
• Nanotechnology-based cytokine delivery strategies in gastrointestinal cancers.

  2025cites this paper
• Oral Peptide Delivery Reimagined: Molecular Barriers, Formulation Strategies, and the Rise of Computational Design

  2025cites this paper
• Recent advances in transition metal-mediated/ catalyzed radiofluorination of arenes and heteroarenes for positron emission tomography.

  2025cites this paper
• Comparison of Different Aliphatic Polyester-Based Microparticles as Protein Delivery Systems

  2025cites this paper
• Luminescent Nanocucurbits Enable Spatiotemporal Co‐Delivery of Hydrophilic and Hydrophobic Chemotherapeutic Agents

  2025cites this paper
• –A novel peptide SMIM45-107aa promotes HCC progression via MTDH pathways and its anticancer peptide derivative

  2025cites this paper
• Nanomedicine for combination of chemodynamic therapy and immunotherapy of cancers.

  2024cites this paper
• Chimeric Peptide-Engineered Polyprodrug Enhances Cytotoxic T Cell Response by Inducing Immunogenic Cell Death and Upregulating Major Histocompatibility Complex Class I.

  2024cites this paper
• A Nucleic Acid‐Based LYTAC Plus Platform to Simultaneously Mediate Disease‐Driven Protein Downregulation

  2024cites this paper
• Liposomes-enabled cancer chemoimmunotherapy.

  2024cites this paper
• Nano‐ and Micro‐Platforms in Therapeutic Proteins Delivery for Cancer Therapy: Materials and Strategies

  2024cites this paper
• A Dynamic Covalent Bonding-based Nanoplatform for Intracellular Co-Delivery of Protein Drugs and Chemotherapeutics with Enhanced Anti-Cancer Effect

  2024cites this paper
• Flavonoids as Potential Therapeutics Against Neurodegenerative Disorders: Unlocking the Prospects

  2024cites this paper
• Injectable thermosensitive microsphere-hydrogel composite system: combined therapy of hepatocellular carcinoma by remodeling tumor immune microenvironment

  2024cites this paper
• Multifunctional nanoparticle-mediated combining therapy for human diseases

  2024cites this paper
• Strategies to address key challenges of metallacycle/metallacage-based supramolecular coordination complexes in biomedical applications.

  2024cites this paper
• Enhancing Gene Therapy through Ultradeformable Vesicles for Efficient siRNA Delivery.

  2024cites this paper
• Chemopreventive Role of Proteins and Polysaccharides from Pleurotus tuber-regium

  2024cites this paper
• Polyphenols Targeting NF-κB Pathway in Neurological Disorders: What We Know So Far?

  2024cites this paper
• Intracellular Biomacromolecule Delivery by Stimuli-Responsive Protein Vesicles Loaded by Hydrophobic Ion Pairing

  2024cites this paper
• ROS-responsive thermosensitive polypeptide hydrogels for localized drug delivery and improved tumor chemoimmunotherapy.

  2024cites this paper
• Enzyme-activatable disk-shaped nanocarriers augment tumor permeability for breast cancer combination therapy

  2024cites this paper
• Recent advances in drug delivery systems for osteosarcoma therapy and bone regeneration

  2024cites this paper
• Nanoparticle-Mediated Synergistic Chemoimmunotherapy for Cancer Treatment

  2024cites this paper
• Multipocket Cage Enables the Binding of High-Order Bulky and Drug Guests Uncovered by MS Methodology.

  2024cites this paper
• A GSH‐Responsive Immune‐Stimulating Polypeptide Hydrogel Loaded with Chemotherapeutics, IDO Inhibitor and Immune Checkpoint Blocking Antibody for Enhanced Anti‐Tumor Chemo‐Immunotherapy

  2024cites this paper
• Nanoplatform-Mediated Autophagy Regulation and Combined Anti-Tumor Therapy for Resistant Tumors

  2024cites this paper
• Harnessing exosomes in theranostic applications: advancements and insights in gastrointestinal cancer research

  2024cites this paper
• Designing Hydrogels for Immunomodulation in Cancer Therapy and Regenerative Medicine

  2023cites this paper
• Smart nanoparticles for cancer therapy

  2023cites this paper
• The Research Progress of Bioactive Peptides Derived from Traditional Natural Products in China

  2023cites this paper
• Atmosphere-inspired multilayered nanoarmor with modulable protection and delivery of Interleukin-4 for inflammatory microenvironment modulation.

  2023cites this paper
• Recent advancements in the targeted delivery of Gemcitabine: Harnessing Nanomedicine for Enhanced Cancer Therapy

  2023cites this paper
• Leveraging efferocytosis blockade for improved cancer chemo-immunotherapy through synchronized release of doxorubicin and BMS777607 confined within tailored mesoporous silica nanoparticles

  2023cites this paper
• An in-vitro quantitative investigation on the synergistic effect of capsaicin and 5-fluorouracil encapsulated into lipid nanocapsules to treat breast cancer

  2023cites this paper
• Bio-Responsive Macromolecular Drug and Small-Molecular Drug Conjugates: Nanoparticulate Prodrugs for Tumor Microenvironment Heterogeneity Management and Therapeutic Response Enhancement.

  2023cites this paper
• Biomimetic Nanoparticle with Glutathione Depletion and Amplified ROS Generation Capabilities for Synergistic Chemo-Sonodynamic Therapy in Squamous Cell Carcinomas.

  2023cites this paper
• Injectable Hydrogels for Personalized Cancer Immunotherapies.

  2023cites this paper
• Application of bismuth sulfide based nanomaterials in cancer diagnosis and treatment

  2023cites this paper
• Pt-N Coordination Rendering the Chemotherapeutic Agent with Photoactivated ROS Generation and Self-Reporting Cell Uptake.

  2023cites this paper
• Oral delivery of anti-PD-L1 antibody for cancer immunotherapy against orthotopic colorectal tumors

  2023cites this paper
• Microneedles for delivery of anticancer therapeutics: recent trends and technologies

  2023cites this paper
• Acid-Responsive Macroporous Silica Nanoparticles for Bcl-2-Functional-Converting Peptide Release and Synergism with Celastrol for Enhanced Therapy against Resistant Cancer.

  2023cites this paper
• Polysaccharide-based nanogels for biomedical applications: A comprehensive review

  2023cites this paper
• Reactive oxygen species-responsive branched poly (β-amino ester) with robust efficiency for cytosolic protein delivery.

  2022cites this paper
• Nanocarriers for intracellular co-delivery of proteins and small-molecule drugs for cancer therapy

  2022cites this paper
• Arsenic trioxide and Erlotinib loaded in RGD‐modified nanoliposomes for targeted combination delivery to PC3 and PANC‐1 cell lines

  2022cites this paper
• Potential of Dual Drug Delivery Systems: MOF as Hybrid Nanocarrier for Dual Drug Delivery in Cancer Treatment

  2022cites this paper
• Intracellular Co-Delivery of Proteins and Chemotherapeutics Using Calcium Carbonate Mineralized Nanoparticles for Osteosarcoma Therapy

  2022cites this paper
• Combinations of chemo-, immuno-, and gene therapies using nanocarriers as a multifunctional drug platform

  2022cites this paper
• Soft Nano and Microstructures for the Photomodulation of Cellular Signaling and Behavior.

  2022cites this paper
• Release of O-GlcNAc transferase inhibitor promotes neuronal differentiation of neural stem cells in 3D bioprinted supramolecular hydrogel scaffold for spinal cord injury repair.

  2022cites this paper
• Co-Encapsulation of l-Asparaginase and Etoposide in Dextran Nanoparticles for Synergistic Effect in Chronic Myeloid Leukemia Cells.

  2022cites this paper
• Ultrasound-mediated immune regulation in tumor immunotherapy

  2022cites this paper
• An injectable thermosensitive hydrogel/nanomicelles composite for local chemo-immunotherapy in mouse model of melanoma

  2022cites this paper
• Characteristics of Marine Biomaterials and Their Applications in Biomedicine

  2022cites this paper
• Dual drug delivery collagen vehicles for modulation of skin fibrosis in vitro

  2022cites this paper
• Biomimetic nanoparticles for tumor immunotherapy

  2022cites this paper
• Recent advances in mesoporous silica nanoparticle-based targeted drug-delivery systems for cancer therapy.

  2022cites this paper
• Enhanced antitumor chemo‐immunotherapy by local co‐delivery of chemotherapeutics, immune checkpoint blocking antibody and IDO inhibitor using an injectable polypeptide hydrogel

  2022cites this paper
• Drug-Loaded Acoustic Nanodroplet for Dual-Imaging Guided Highly Efficient Chemotherapy Against Nasopharyngeal Carcinoma

  2022cites this paper
• Janus Micro/Nanorobots in Biomedical Applications

  2022cites this paper
• Self-delivery of metal-coordinated mitochondria protonophore uncoupler for O2-exhausting enhanced bioreductive therapy.

  2022cites this paper
• Microfluidics-Assisted Engineering of pH/Enzyme Dual-Activatable ZIF@Polymer Nanosystem for Co-Delivery of Proteins and Chemotherapeutics with Enhanced Deep-Tumor Penetration.

  2022cites this paper
• Advances in Lipid‐Based Codelivery Systems for Cancer and Inflammatory Diseases

  2022cites this paper
• Intracellular Co-delivery of native antibody and siRNA for combination therapy by using biodegradable silica nanocapsules.

  2022cites this paper
• Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: a review

  2022cites this paper
• Molecularly engineered tumor acidity-responsive plant toxin gelonin for safe and efficient cancer therapy

  2022cites this paper
• Locally Injectable Hydrogels for Tumor Immunotherapy

  2021cites this paper
• Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment

  2021cites this paper
• Pulmonary Co-delivery of DOX and siRNA

  2021cites this paper
• Managing GSH elevation and hypoxia to overcome resistance of cancer therapies using functionalized nanocarriers

  2021cites this paper
• Nanoparticle-mediated synergistic chemoimmunotherapy for tailoring cancer therapy: recent advances and perspectives

  2021cites this paper
• Antitumor activity of iRGD-modified red blood cell membrane nanoparticles loaded with Juglone and Oxaliplatin against colorectal cancer

  2021cites this paper
• Cyclophosphamide loaded thermo-responsive hydrogel system synergize with a hydrogel cancer vaccine to amplify cancer immunotherapy in a prime-boost manner

  2021cites this paper
• Responsive polymeric drug delivery systems for combination anticancer therapy: experimental design and computational insights

  2021cites this paper
• Co-delivery of glial cell–derived neurotrophic factor (GDNF) and tauroursodeoxycholic acid (TUDCA) from PLGA microspheres: potential combination therapy for retinal diseases

  2021cites this paper
• Cetuximab functionalization strategy for combining active targeting and antimigration capacities of a hybrid composite nanoplatform applied to deliver 5-fluorouracil: toward colorectal cancer treatment.

  2021cites this paper
• Immunogenic Cell Death Induced by Chemoradiotherapy of Novel pH-Sensitive Cargo-Loaded Polymersomes in Glioblastoma

  2021cites this paper
• Nanomaterials for Protein Delivery in Anticancer Applications

  2021cites this paper
• Supramolecular nanofibers increase the efficacy of 10-hydroxycamptothecin by enhancing nuclear accumulation and depleting cellular ATP.

  2021cites this paper
• Injectable Hydrogels as Local Depots at Tumor Sites for Antitumor Immunotherapy and Immune-Based Combination Therapy.

  2021cites this paper
• A Safe GDNF and GDNF/BDNF Controlled Delivery System Improves Migration in Human Retinal Pigment Epithelial Cells and Survival in Retinal Ganglion Cells: Potential Usefulness in Degenerative Retinal Pathologies

  2021cites this paper
• Microfluidic Assembly of Small-Molecule Prodrug Cocktail Nanoparticles with High Reproducibility for Synergistic Combination of Cancer Therapy.

  2021cites this paper